Back to Results
First PageMeta Content
Syndromes / Biology / Medicine / Long QT syndrome / KCNE1 / KvLQT1 / Hypertrophic cardiomyopathy / QT interval / Genetic testing / Health / Cardiac dysrhythmia / Channelopathy


Horizon Scanning Technology
Add to Reading List

Document Date: 2015-03-17 04:52:31

Open Document

File Size: 256,88 KB

Share Result on Facebook

City

Auckland / /

Company

QT SYNDROME PURPOSE AND TARGET GROUP / Genaissance Pharmaceuticals Inc. / USE Limited / /

Country

United States / Australia / New Zealand / /

Currency

USD / NZD / /

Facility

Royal Children’s Hospital / University of Adelaide / /

Holiday

Commonwealth Day of Australia / /

IndustryTerm

health technology / non-carrier family members / literature search / /

MedicalCondition

congenital deafness / arrhythmia / viral myocarditis / BACKGROUND Long QT syndrome / hypertrophic cardiomyopathy / congenital heart disease / disease / sudden cardiac death / sudden cardiac failure / genetic disorder / inherited long QT syndrome / probable primary arrhythmia / syncope / torsade de pointes / Romano Ward syndrome / injury / deafness / coronary artery disease / Cardiac arrest / sudden infant death syndrome / unexplained sudden cardiac death / QT SYNDROME / genetic disorders / Long QT syndrome / /

MedicalTreatment

antibiotics / /

Organization

University of Adelaide / Health Policy Advisory Committee on Technology / Royal Children’s Hospital in Melbourne / National Horizon Scanning Unit / THERAPEUTIC GOODS ADMINISTRATION / Commonwealth Copyright Administration / Department of Health / Australian Health Ministers’ Advisory Council / Medical Services Advisory Committee / Attorney General’s Department / Medicare / /

Person

Janet Hiller / Linda Mundy / Andrew Davis / /

Position

Governor / Major / /

ProvinceOrState

South Australia / /

Region

South Australia / /

Technology

health technology / health technologies / DNA sequencing / genotyping / genotype / gene analysis / /

URL

http /

SocialTag